title: Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin.
abstract: Interferon alpha-producing plasmacytoid dendritic cells (pDC) are crucial contributors to pro-inflammatory or tolerogenic immune responses and are important in autoimmune diseases such as psoriasis. pDC accumulate in the lesional skin of psoriasis patients, but are rarely found in the affected skin of patients with atopic dermatitis (AD). While homeostatic chemokine CXCL12 and inducible pro-inflammatory CXCR3 chemokine ligands may regulate pDC influx to psoriatic skin, the mechanism responsible for selective pDC recruitment in psoriasis vs. AD remains unknown. Circulating pDC from normal donors express a limited number of chemoattractant receptors, including CXCR3 and CMKLR1 (chemokine-like receptor 1). In this work, we demonstrate that circulating pDC from normal donors as well as psoriasis and AD patients express similar levels of CXCR3 and responded similarly in functional migration assays to CXCL10. We next found that blood pDC from normal, AD, and psoriasis patients express functional CMKLR1. In contrast to normal skin, however, lesional skin from psoriasis patients contains the active form of the CMKLR1 ligand chemerin. Furthermore, in affected skin from psoriatic patients the level of active chemerin was generally higher than in AD skin. Taken together, these results indicate that local generation of active chemerin may contribute to pDC recruitment to psoriatic skin.
authors.affiliation: Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7 St., 30-387 Krakow, Poland.
authors.forename: J
authors.initials: J
authors.lastname: Skrzeczyńska-Moncznik
authors.forename: K
authors.initials: K
authors.lastname: Wawro
authors.forename: A
authors.initials: A
authors.lastname: Stefańska
authors.forename: E
authors.initials: E
authors.lastname: Oleszycka
authors.forename: P
authors.initials: P
authors.lastname: Kulig
authors.forename: B A
authors.initials: BA
authors.lastname: Zabel
authors.forename: M
authors.initials: M
authors.lastname: Sułkowski
authors.forename: M
authors.initials: M
authors.lastname: Kapińska-Mrowiecka
authors.forename: M
authors.initials: M
authors.lastname: Czubak-Macugowska
authors.forename: E C
authors.initials: EC
authors.lastname: Butcher
authors.forename: J
authors.initials: J
authors.lastname: Cichy
mesh_terms: D000328:Adult; D002465:Cell Movement / Q000187:drug effects / Q000276:immunology*; D054357:Chemokine CXCL10 / Q000494:pharmacology; D018925:Chemokines / Q000096:biosynthesis / Q000502:physiology*; D003713:Dendritic Cells / Q000187:drug effects / Q000276:immunology*; D003876:Dermatitis, Atopic / Q000276:immunology*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D011565:Psoriasis / Q000276:immunology*; D054367:Receptors, CXCR3 / Q000096:biosynthesis; D019707:Receptors, Chemokine / Q000096:biosynthesis / Q000502:physiology*; D012867:Skin / Q000276:immunology; D055815:Young Adult
chemical_list: C102741:CMKLR1 protein, human; C114753:CXCL10 protein, human; C515187:CXCR3 protein, human; D054357:Chemokine CXCL10; D018925:Chemokines; D036341:Intercellular Signaling Peptides and Proteins; C478630:RARRES2 protein, human; D054367:Receptors, CXCR3; D019707:Receptors, Chemokine